is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
The Melody iCTG mobile fetal monitor – the smallest approved fetal monitor on the market – uses this principle of Doppler-based fetal monitoring with ‘real time adaptive autocorrelation’ to monitor the pregnancy.
Melody iCTG is composed of two small devices worn by the expectant mother. One device measures the fetal heart rate, and the other measures uterine contractions.
In 1974, Prof. Kazuhiro Hara and Prof. Yasuhito Takeuchi (today advisors to Melody Intl.) made a disruptive breakthrough on Doppler-based fetal monitoring systems with their ‘real time adaptive autocorrelation’ method – now the de-facto standard in this field implemented in virtually all clinical fetal monitoring. Melody International Ltd. developed iCTG, the smallest fetal monitor in the world that uses the principle of real time autocorrelation. Despite its size, iCTG has the same functionality as conventional hospital-based machines and is approved by Japan’s PMDA. Until now, such technology was only available only inside the hospital, but iCTG’s portability allows it to be used at any location, even by non-medical personnel. Together, Abdul Latif Jameel Health and Melody Intl. aim to reduce the risk of perinatal emergencies or deaths across the region.